Aligos Therapeutics, Inc.

ALGS · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$41,946$18,661$73,763$36,997
Short-Term Investments$57,150$104,284$64,098$19,942
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$4,339$4,999$5,344$5,202
Total Curr. Assets$103,435$127,944$143,205$62,141
Property Plant & Equip (Net)$5,616$6,122$6,862$7,326
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$713$640$632$627
Total NC Assets$6,329$6,762$7,494$7,953
Other Assets$0$0$0$0
Total Assets$109,764$134,706$150,699$70,094
Liabilities
Payables$4,651$3,937$4,460$2,571
Short-Term Debt$3,563$3,540$3,487$3,458
Tax Payable$0$0$0$0
Deferred Revenue$168$579$0$151
Other Curr. Liab.$13,605$12,209$11,001$15,557
Total Curr. Liab.$21,987$20,265$18,948$21,737
LT Debt$2,502$3,338$4,387$4,917
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$13,442$9,237$10,919$72,413
Total NC Liab.$15,944$12,575$15,306$77,330
Other Liabilities$0$0$0$0
Cap. Leases$0$6,878$7,874$8,375
Total Liabilities$37,931$32,840$34,254$99,067
Equity
Pref Stock$0$0$0$0
Common Stock$9$9$9$8
Retained Earnings-$622,320-$590,783-$574,920-$618,008
AOCI$455$420$447$451
Other Equity$693,689$692,220$690,909$588,576
Total Equity$71,833$101,866$116,445-$28,973
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$109,764$134,706$150,699$70,094
Net Debt-$35,881-$11,783-$65,889-$28,622
Aligos Therapeutics, Inc. (ALGS) Financial Statements & Key Stats | AlphaPilot